AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Olencki, T Peereboom, D Wood, L Budd, GT Novick, A Finke, J McLain, D Elson, P Bukowski, RM
Citation: T. Olencki et al., Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma, J CANC RES, 127(5), 2001, pp. 319-324

Authors: Hussein, MA Sandstrom, K Elson, P Finke, J McLain, D Rayman, P Rybicki, LA Bukowski, RA
Citation: Ma. Hussein et al., GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial, J CANC RES, 127(10), 2001, pp. 619-624

Authors: Olencki, T Finke, J Tubbs, R Elson, P McLain, D Herzog, P Budd, GT Gunn, H Bukowski, RM
Citation: T. Olencki et al., Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects, J IMMUNOTH, 23(5), 2000, pp. 549-556

Authors: van Stolk, R Stoner, G Hayton, WL Chan, K DeYoung, B Kresty, L Kemmenoe, BH Elson, P Rybicki, L Church, J Provencher, K McLain, D Hawk, E Fryer, B Kelloff, G Ganapathi, R Budd, GT
Citation: R. Van Stolk et al., Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis, CLIN CANC R, 6(1), 2000, pp. 78-89

Authors: Pelley, R Ganapathi, R Wood, L Rybicki, L McLain, D Budd, GT Peereboom, D Olencki, T Bukowski, RM
Citation: R. Pelley et al., A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer, CANC CHEMOT, 46(3), 2000, pp. 251-254

Authors: Chidiac, T Budd, GT Pelley, R Sandstrom, K McLain, D Elson, P Crownover, R Marks, K Muschler, G Joyce, M Zehr, R Bukowski, R
Citation: T. Chidiac et al., Phase II trial of liposomal doxorubicin (Doxil (R)) in advanced soft tissue sarcomas, INV NEW DR, 18(3), 2000, pp. 253-259

Authors: Wolkomir, R McLain, D
Citation: R. Wolkomir et D. Mclain, Shod for snow - Whether they're strapping on traditional or high-tech footgear, snowshoers are mushing into winter, SMITHSONIAN, 31(9), 2000, pp. 90

Authors: Holland, MM Burk, CJ McLain, D
Citation: Mm. Holland et al., Long-term vegetation dynamics of the lower strata of a western Massachusetts oxbow swamp forest, RHODORA, 102(910), 2000, pp. 154-174

Authors: Bukowski, RM Rayman, P Molto, L Tannenbaum, CS Olencki, T Peereboom, D Tubbs, R McLain, D Budd, GT Griffin, T Novick, A Hamilton, TA Finke, J
Citation: Rm. Bukowski et al., Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma, CLIN CANC R, 5(10), 1999, pp. 2780-2789

Authors: Budd, GT Ganapathi, R Wood, L Snyder, J McLain, D Bukowski, RM
Citation: Gt. Budd et al., Approaches to managing carboplatin-induced thrombocytopenia: Focus on the role of amifostine, SEMIN ONCOL, 26(2), 1999, pp. 41-50

Authors: Rajagopalan, K Peereboom, D Budd, GT Olencki, T Murthy, S Elson, P McLain, D Bukowski, R
Citation: K. Rajagopalan et al., Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer, INV NEW DR, 16(3), 1998, pp. 255-258
Risultati: 1-11 |